Cardiac levels of NOS1AP RNA from right ventricular tissue recovered during lead extraction

Published:October 20, 2011DOI:


      There is a scarcity of cardiac tissue available for research.


      (1) To investigate the feasibility of obtaining myocardial tissue from extracted pacemaker and defibrillator leads for gene expression analysis and (2) to examine the nitric oxide 1 adaptor protein (NOS1AP) RNA expression as a function of patient genotype.


      Seventeen patients (age = 56 ± 20 years; 12 men; 5 pacemakers; 12 defibrillators) undergoing lead extractions for standard indications (5 device erosion; 1 vascular occlusion; 11 lead malfunction or recall) were genotyped for 2 NOS1AP single nucleotide polymorphisms—rs10494366 (T to G) and rs10918594 (C to G)—and had RNA levels measured by real-time polymerase chain reaction for collagen I, troponin I, Cav1.2, Kv4.3, HERG, KvLQT1, connexin 43, NOS1AP, and sodium–calcium exchanger. Ventricular tissue obtained from 3 failing hearts at transplantation served as reference.


      A high ratio of cardiac troponin I/collagen I RNA identified 9 of the 17 patient samples (muscle rich), in which the gene expression profile was similar to that of the reference ventricular samples and significantly different (P < .003) from the expression profile of samples with a low troponin I/collagen ratio (muscle poor). TT and CC polymorphisms were associated with significantly lower NOS1AP RNA levels (P < .01 compared with the GG genotype).


      Performing gene expression analyses on right ventricular tissue samples extracted with pacemaker and defibrillator leads is feasible. A significant number of samples contain cardiomyocytes that express troponin I and ion channels at levels comparable to those seen in explanted hearts. Decreased NOS1AP expression in rs10494366 TT and rs10918594 CC homozygotes may underlie shorter repolarization times.



      CIED (cardiac implantable electronic device), ECG (electrocardiogram), NCX (sodium–calcium exchanger), NOS1AP (nitric oxide 1 adaptor protein), RT-PCR (real-time polymerase chain reaction), RV (right ventricular)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • et al.
        ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
        Circulation. 2008; 117: e350-e408
        • Kuck K.H.
        • Cappato R.
        • Siebels J.
        • Ruppel R.
        • CASH Investigators
        Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH).
        Circulation. 2000; 102: 748-754
        • Connolly S.J.
        • Gent M.
        • Roberts R.S.
        • et al.
        Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone.
        Circulation. 2000; 101: 1297-1302
        • The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
        A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
        N Engl J Med. 1997; 337: 1576-1583
        • Moss A.J.
        • Hall W.J.
        • Cannom D.S.
        • et al.
        • Multicenter Automatic Defibrillator Implantation Trial Investigators
        Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.
        N Engl J Med. 1996; 335: 1933-1940
        • Buxton A.E.
        • Lee K.L.
        • Fisher J.D.
        • et al.
        • Multicenter Unsustained Tachycardia Trial Investigators
        A randomized study of the prevention of sudden death in patients with coronary artery disease.
        N Engl J Med. 1999; 341: 1882-1890
        • Moss A.J.
        • Zareba W.
        • Hall W.J.
        • et al.
        Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
        N Engl J Med. 2002; 346: 877-883
        • Bardy G.H.
        • Lee K.L.
        • Mark D.B.
        • et al.
        Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
        N Engl J Med. 2005; 352: 225-237
        • Cleland J.G.
        • Daubert J.C.
        • Erdmann E.
        • et al.
        The effect of cardiac resynchronization on morbidity and mortality in heart failure.
        N Engl J Med. 2005; 352: 1539-1549
        • Bristow M.R.
        • Saxon L.A.
        • Boehmer J.
        • et al.
        Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
        N Engl J Med. 2004; 350: 2140-2150
        • Moss A.J.
        • Hall W.J.
        • Cannom D.S.
        • et al.
        • MADIT-CRT Trial Investigators
        Cardiac-resynchronization therapy for the prevention of heart-failure events.
        N Engl J Med. 2009; 361: 1329-1338
        • Wilkoff B.L.
        • Love C.J.
        • Byrd C.L.
        • et al.
        • Heart Rhythm Society
        • American Heart Association
        Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management.
        Heart Rhythm. 2009; 6: 1085-1104
        • Voigt A.
        • Shalaby A.
        • Saba S.
        Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003.
        J Am Coll Cardiol. 2006; 48: 590-591
        • Voigt A.
        • Shalaby A.
        • Saba S.
        Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights.
        Pacing Clin Electrophysiol. 2010; 33: 414-419
        • Frustaci A.
        • Chimenti C.
        • Bellocci F.
        • Morgante E.
        • Russo M.A.
        • Maseri A.
        Histological substrate of atrial biopsies in patients with lone atrial fibrillation.
        Circulation. 1997; 96: 1180-1184
        • Issac T.T.
        • Dokainish H.
        • Lakkis N.M.
        Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.
        J Am Coll Cardiol. 2007; 50: 2021-2028
        • Blangy H.
        • Sadoul N.
        • Dousset B.
        • et al.
        Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction.
        Europace. 2007; 9: 724-729
        • Kao W.H.
        • Arking D.E.
        • Post W.
        • et al.
        Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.
        Circulation. 2009; 119: 940-951
        • Eijgelsheim M.
        • Aarnoudse A.L.
        • Rivadeneira F.
        • et al.
        Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.
        Hum Mol Genet. 2009; 18: 347-357
        • Arking D.E.
        • Pfeufer A.
        • Post W.
        • et al.
        A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.
        Nat Genet. 2006; 38: 644-651
        • Aarnoudse A.J.
        • Newton-Cheh C.
        • de Bakker P.I.
        • et al.
        Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam study.
        Circulation. 2007; 116: 10-16
        • Post W.
        • Shen H.
        • Damcott C.
        • et al.
        Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the older order Amish.
        Hum Hered. 2007; 64: 214-219
        • Tobin M.D.
        • Kahonen M.
        • Braund P.
        • et al.
        Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
        Int J Epidemiol. 2008; 37: 1132-1141
        • Spooner P.M.
        Sudden cardiac death: the larger problem …the larger genome.
        J Cardiovasc Electrophysiol. 2009; 20: 585-596
        • Cooper L.T.
        • Baughman K.L.
        • Feldman A.M.
        • et al.
        The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.
        Circulation. 2007; 116: 2216-2233
        • Fang Y.
        • van Meurs J.B.
        • d'Alesio A.
        • et al.
        Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study.
        Am J Hum Genet. 2005; 77: 807-823
        • Rose J.
        • Armoundas A.A.
        • Tian Y.
        • et al.
        Molecular correlates of altered expression of potassium currents in failing rabbit myocardium.
        Am J Physiol Heart Circ Physiol. 2005; 288: H2077-H2087
        • Gaborit N.
        • Le Bouter S.
        • Szuts V.
        • et al.
        Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.
        J Physiol. 2007; 582: 675-693
        • Leoni A.L.
        • Marionneau A.C.
        • Demolombe S.
        • et al.
        Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle.
        Physiol Genom. 2005; 24: 4-12